1 Market Overview

1.1 Product Overview and Scope of Pharmaceutical Products and CMO

1.2 Classification of Pharmaceutical Products and CMO by Type

1.2.1 Overview: Global Pharmaceutical Products and CMO Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Pharmaceutical Products and CMO Revenue Market Share by Type in 2021

1.2.3 Active Pharmaceutical Ingredient (API)

1.2.4 Finished Dosage Form (FDF)

1.2.5 Pharmaceutical Packaging

1.3 Global Pharmaceutical Products and CMO Market by Application

1.3.1 Overview: Global Pharmaceutical Products and CMO Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Specialty/Midsize

1.3.3 Generics

1.3.4 Big Pharma

1.3.5 Others

1.4 Global Pharmaceutical Products and CMO Market Size & Forecast

1.5 Global Pharmaceutical Products and CMO Market Size and Forecast by Region

1.5.1 Global Pharmaceutical Products and CMO Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Pharmaceutical Products and CMO Market Size by Region, (2017-2022)

1.5.3 North America Pharmaceutical Products and CMO Market Size and Prospect (2017-2028)

1.5.4 Europe Pharmaceutical Products and CMO Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Pharmaceutical Products and CMO Market Size and Prospect (2017-2028)

1.5.6 South America Pharmaceutical Products and CMO Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Pharmaceutical Products and CMO Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmaceutical Products and CMO Market Drivers

1.6.2 Pharmaceutical Products and CMO Market Restraints

1.6.3 Pharmaceutical Products and CMO Trends Analysis

2 Company Profiles

2.1 Catalent

2.1.1 Catalent Details

2.1.2 Catalent Major Business

2.1.3 Catalent Pharmaceutical Products and CMO Product and Solutions

2.1.4 Catalent Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Catalent Recent Developments and Future Plans

2.2 DPx

2.2.1 DPx Details

2.2.2 DPx Major Business

2.2.3 DPx Pharmaceutical Products and CMO Product and Solutions

2.2.4 DPx Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 DPx Recent Developments and Future Plans

2.3 Lonza

2.3.1 Lonza Details

2.3.2 Lonza Major Business

2.3.3 Lonza Pharmaceutical Products and CMO Product and Solutions

2.3.4 Lonza Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Lonza Recent Developments and Future Plans

2.4 Piramal Healthcare

2.4.1 Piramal Healthcare Details

2.4.2 Piramal Healthcare Major Business

2.4.3 Piramal Healthcare Pharmaceutical Products and CMO Product and Solutions

2.4.4 Piramal Healthcare Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Piramal Healthcare Recent Developments and Future Plans

2.5 Aenova

2.5.1 Aenova Details

2.5.2 Aenova Major Business

2.5.3 Aenova Pharmaceutical Products and CMO Product and Solutions

2.5.4 Aenova Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Aenova Recent Developments and Future Plans

2.6 Jubilant

2.6.1 Jubilant Details

2.6.2 Jubilant Major Business

2.6.3 Jubilant Pharmaceutical Products and CMO Product and Solutions

2.6.4 Jubilant Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Jubilant Recent Developments and Future Plans

2.7 Famar

2.7.1 Famar Details

2.7.2 Famar Major Business

2.7.3 Famar Pharmaceutical Products and CMO Product and Solutions

2.7.4 Famar Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Famar Recent Developments and Future Plans

2.8 Boehringer Ingelheim

2.8.1 Boehringer Ingelheim Details

2.8.2 Boehringer Ingelheim Major Business

2.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Product and Solutions

2.8.4 Boehringer Ingelheim Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Boehringer Ingelheim Recent Developments and Future Plans

2.9 Fareva Holding

2.9.1 Fareva Holding Details

2.9.2 Fareva Holding Major Business

2.9.3 Fareva Holding Pharmaceutical Products and CMO Product and Solutions

2.9.4 Fareva Holding Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Fareva Holding Recent Developments and Future Plans

2.10 AbbVie

2.10.1 AbbVie Details

2.10.2 AbbVie Major Business

2.10.3 AbbVie Pharmaceutical Products and CMO Product and Solutions

2.10.4 AbbVie Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 AbbVie Recent Developments and Future Plans

2.11 Nipro Corp

2.11.1 Nipro Corp Details

2.11.2 Nipro Corp Major Business

2.11.3 Nipro Corp Pharmaceutical Products and CMO Product and Solutions

2.11.4 Nipro Corp Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Nipro Corp Recent Developments and Future Plans

2.12 Vetter

2.12.1 Vetter Details

2.12.2 Vetter Major Business

2.12.3 Vetter Pharmaceutical Products and CMO Product and Solutions

2.12.4 Vetter Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Vetter Recent Developments and Future Plans

2.13 Sopharma

2.13.1 Sopharma Details

2.13.2 Sopharma Major Business

2.13.3 Sopharma Pharmaceutical Products and CMO Product and Solutions

2.13.4 Sopharma Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Sopharma Recent Developments and Future Plans

2.14 Mylan (DPT Laboratories)

2.14.1 Mylan (DPT Laboratories) Details

2.14.2 Mylan (DPT Laboratories) Major Business

2.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product and Solutions

2.14.4 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Mylan (DPT Laboratories) Recent Developments and Future Plans

2.15 Recipharm

2.15.1 Recipharm Details

2.15.2 Recipharm Major Business

2.15.3 Recipharm Pharmaceutical Products and CMO Product and Solutions

2.15.4 Recipharm Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Recipharm Recent Developments and Future Plans

2.16 NextPharma Technologies

2.16.1 NextPharma Technologies Details

2.16.2 NextPharma Technologies Major Business

2.16.3 NextPharma Technologies Pharmaceutical Products and CMO Product and Solutions

2.16.4 NextPharma Technologies Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 NextPharma Technologies Recent Developments and Future Plans

2.17 Dishman

2.17.1 Dishman Details

2.17.2 Dishman Major Business

2.17.3 Dishman Pharmaceutical Products and CMO Product and Solutions

2.17.4 Dishman Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Dishman Recent Developments and Future Plans

2.18 Aesica

2.18.1 Aesica Details

2.18.2 Aesica Major Business

2.18.3 Aesica Pharmaceutical Products and CMO Product and Solutions

2.18.4 Aesica Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Aesica Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceutical Products and CMO Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmaceutical Products and CMO Players Market Share in 2021

3.2.2 Top 10 Pharmaceutical Products and CMO Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Pharmaceutical Products and CMO Players Head Office, Products and Services Provided

3.4 Pharmaceutical Products and CMO Mergers & Acquisitions

3.5 Pharmaceutical Products and CMO New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmaceutical Products and CMO Revenue and Market Share by Type (2017-2022)

4.2 Global Pharmaceutical Products and CMO Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Pharmaceutical Products and CMO Revenue Market Share by Application (2017-2022)

5.2 Global Pharmaceutical Products and CMO Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Pharmaceutical Products and CMO Revenue by Type (2017-2028)

6.2 North America Pharmaceutical Products and CMO Revenue by Application (2017-2028)

6.3 North America Pharmaceutical Products and CMO Market Size by Country

6.3.1 North America Pharmaceutical Products and CMO Revenue by Country (2017-2028)

6.3.2 United States Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

6.3.3 Canada Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

6.3.4 Mexico Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmaceutical Products and CMO Revenue by Type (2017-2028)

7.2 Europe Pharmaceutical Products and CMO Revenue by Application (2017-2028)

7.3 Europe Pharmaceutical Products and CMO Market Size by Country

7.3.1 Europe Pharmaceutical Products and CMO Revenue by Country (2017-2028)

7.3.2 Germany Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

7.3.3 France Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

7.3.5 Russia Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

7.3.6 Italy Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmaceutical Products and CMO Revenue by Type (2017-2028)

8.2 Asia-Pacific Pharmaceutical Products and CMO Revenue by Application (2017-2028)

8.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region

8.3.1 Asia-Pacific Pharmaceutical Products and CMO Revenue by Region (2017-2028)

8.3.2 China Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

8.3.3 Japan Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

8.3.4 South Korea Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

8.3.5 India Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

8.3.7 Australia Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Pharmaceutical Products and CMO Revenue by Type (2017-2028)

9.2 South America Pharmaceutical Products and CMO Revenue by Application (2017-2028)

9.3 South America Pharmaceutical Products and CMO Market Size by Country

9.3.1 South America Pharmaceutical Products and CMO Revenue by Country (2017-2028)

9.3.2 Brazil Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

9.3.3 Argentina Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmaceutical Products and CMO Revenue by Type (2017-2028)

10.2 Middle East & Africa Pharmaceutical Products and CMO Revenue by Application (2017-2028)

10.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country

10.3.1 Middle East & Africa Pharmaceutical Products and CMO Revenue by Country (2017-2028)

10.3.2 Turkey Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

10.3.4 UAE Pharmaceutical Products and CMO Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmaceutical Products and CMO Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Pharmaceutical Products and CMO Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Pharmaceutical Products and CMO Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Pharmaceutical Products and CMO Revenue (USD Million) by Region (2017-2022)

Table 5. Global Pharmaceutical Products and CMO Revenue Market Share by Region (2023-2028)

Table 6. Catalent Corporate Information, Head Office, and Major Competitors

Table 7. Catalent Major Business

Table 8. Catalent Pharmaceutical Products and CMO Product and Solutions

Table 9. Catalent Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. DPx Corporate Information, Head Office, and Major Competitors

Table 11. DPx Major Business

Table 12. DPx Pharmaceutical Products and CMO Product and Solutions

Table 13. DPx Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Lonza Corporate Information, Head Office, and Major Competitors

Table 15. Lonza Major Business

Table 16. Lonza Pharmaceutical Products and CMO Product and Solutions

Table 17. Lonza Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Piramal Healthcare Corporate Information, Head Office, and Major Competitors

Table 19. Piramal Healthcare Major Business

Table 20. Piramal Healthcare Pharmaceutical Products and CMO Product and Solutions

Table 21. Piramal Healthcare Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Aenova Corporate Information, Head Office, and Major Competitors

Table 23. Aenova Major Business

Table 24. Aenova Pharmaceutical Products and CMO Product and Solutions

Table 25. Aenova Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Jubilant Corporate Information, Head Office, and Major Competitors

Table 27. Jubilant Major Business

Table 28. Jubilant Pharmaceutical Products and CMO Product and Solutions

Table 29. Jubilant Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Famar Corporate Information, Head Office, and Major Competitors

Table 31. Famar Major Business

Table 32. Famar Pharmaceutical Products and CMO Product and Solutions

Table 33. Famar Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 35. Boehringer Ingelheim Major Business

Table 36. Boehringer Ingelheim Pharmaceutical Products and CMO Product and Solutions

Table 37. Boehringer Ingelheim Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Fareva Holding Corporate Information, Head Office, and Major Competitors

Table 39. Fareva Holding Major Business

Table 40. Fareva Holding Pharmaceutical Products and CMO Product and Solutions

Table 41. Fareva Holding Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. AbbVie Corporate Information, Head Office, and Major Competitors

Table 43. AbbVie Major Business

Table 44. AbbVie Pharmaceutical Products and CMO Product and Solutions

Table 45. AbbVie Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Nipro Corp Corporate Information, Head Office, and Major Competitors

Table 47. Nipro Corp Major Business

Table 48. Nipro Corp Pharmaceutical Products and CMO Product and Solutions

Table 49. Nipro Corp Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Vetter Corporate Information, Head Office, and Major Competitors

Table 51. Vetter Major Business

Table 52. Vetter Pharmaceutical Products and CMO Product and Solutions

Table 53. Vetter Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Sopharma Corporate Information, Head Office, and Major Competitors

Table 55. Sopharma Major Business

Table 56. Sopharma Pharmaceutical Products and CMO Product and Solutions

Table 57. Sopharma Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Mylan (DPT Laboratories) Corporate Information, Head Office, and Major Competitors

Table 59. Mylan (DPT Laboratories) Major Business

Table 60. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product and Solutions

Table 61. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Recipharm Corporate Information, Head Office, and Major Competitors

Table 63. Recipharm Major Business

Table 64. Recipharm Pharmaceutical Products and CMO Product and Solutions

Table 65. Recipharm Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. NextPharma Technologies Corporate Information, Head Office, and Major Competitors

Table 67. NextPharma Technologies Major Business

Table 68. NextPharma Technologies Pharmaceutical Products and CMO Product and Solutions

Table 69. NextPharma Technologies Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Dishman Corporate Information, Head Office, and Major Competitors

Table 71. Dishman Major Business

Table 72. Dishman Pharmaceutical Products and CMO Product and Solutions

Table 73. Dishman Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Aesica Corporate Information, Head Office, and Major Competitors

Table 75. Aesica Major Business

Table 76. Aesica Pharmaceutical Products and CMO Product and Solutions

Table 77. Aesica Pharmaceutical Products and CMO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Global Pharmaceutical Products and CMO Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 79. Global Pharmaceutical Products and CMO Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 80. Breakdown of Pharmaceutical Products and CMO by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. Pharmaceutical Products and CMO Players Head Office, Products and Services Provided

Table 82. Pharmaceutical Products and CMO Mergers & Acquisitions in the Past Five Years

Table 83. Pharmaceutical Products and CMO New Entrants and Expansion Plans

Table 84. Global Pharmaceutical Products and CMO Revenue (USD Million) by Type (2017-2022)

Table 85. Global Pharmaceutical Products and CMO Revenue Share by Type (2017-2022)

Table 86. Global Pharmaceutical Products and CMO Revenue Forecast by Type (2023-2028)

Table 87. Global Pharmaceutical Products and CMO Revenue by Application (2017-2022)

Table 88. Global Pharmaceutical Products and CMO Revenue Forecast by Application (2023-2028)

Table 89. North America Pharmaceutical Products and CMO Revenue by Type (2017-2022) & (USD Million)

Table 90. North America Pharmaceutical Products and CMO Revenue by Type (2023-2028) & (USD Million)

Table 91. North America Pharmaceutical Products and CMO Revenue by Application (2017-2022) & (USD Million)

Table 92. North America Pharmaceutical Products and CMO Revenue by Application (2023-2028) & (USD Million)

Table 93. North America Pharmaceutical Products and CMO Revenue by Country (2017-2022) & (USD Million)

Table 94. North America Pharmaceutical Products and CMO Revenue by Country (2023-2028) & (USD Million)

Table 95. Europe Pharmaceutical Products and CMO Revenue by Type (2017-2022) & (USD Million)

Table 96. Europe Pharmaceutical Products and CMO Revenue by Type (2023-2028) & (USD Million)

Table 97. Europe Pharmaceutical Products and CMO Revenue by Application (2017-2022) & (USD Million)

Table 98. Europe Pharmaceutical Products and CMO Revenue by Application (2023-2028) & (USD Million)

Table 99. Europe Pharmaceutical Products and CMO Revenue by Country (2017-2022) & (USD Million)

Table 100. Europe Pharmaceutical Products and CMO Revenue by Country (2023-2028) & (USD Million)

Table 101. Asia-Pacific Pharmaceutical Products and CMO Revenue by Type (2017-2022) & (USD Million)

Table 102. Asia-Pacific Pharmaceutical Products and CMO Revenue by Type (2023-2028) & (USD Million)

Table 103. Asia-Pacific Pharmaceutical Products and CMO Revenue by Application (2017-2022) & (USD Million)

Table 104. Asia-Pacific Pharmaceutical Products and CMO Revenue by Application (2023-2028) & (USD Million)

Table 105. Asia-Pacific Pharmaceutical Products and CMO Revenue by Region (2017-2022) & (USD Million)

Table 106. Asia-Pacific Pharmaceutical Products and CMO Revenue by Region (2023-2028) & (USD Million)

Table 107. South America Pharmaceutical Products and CMO Revenue by Type (2017-2022) & (USD Million)

Table 108. South America Pharmaceutical Products and CMO Revenue by Type (2023-2028) & (USD Million)

Table 109. South America Pharmaceutical Products and CMO Revenue by Application (2017-2022) & (USD Million)

Table 110. South America Pharmaceutical Products and CMO Revenue by Application (2023-2028) & (USD Million)

Table 111. South America Pharmaceutical Products and CMO Revenue by Country (2017-2022) & (USD Million)

Table 112. South America Pharmaceutical Products and CMO Revenue by Country (2023-2028) & (USD Million)

Table 113. Middle East & Africa Pharmaceutical Products and CMO Revenue by Type (2017-2022) & (USD Million)

Table 114. Middle East & Africa Pharmaceutical Products and CMO Revenue by Type (2023-2028) & (USD Million)

Table 115. Middle East & Africa Pharmaceutical Products and CMO Revenue by Application (2017-2022) & (USD Million)

Table 116. Middle East & Africa Pharmaceutical Products and CMO Revenue by Application (2023-2028) & (USD Million)

Table 117. Middle East & Africa Pharmaceutical Products and CMO Revenue by Country (2017-2022) & (USD Million)

Table 118. Middle East & Africa Pharmaceutical Products and CMO Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Pharmaceutical Products and CMO Picture

Figure 2. Global Pharmaceutical Products and CMO Revenue Market Share by Type in 2021

Figure 3. Active Pharmaceutical Ingredient (API)

Figure 4. Finished Dosage Form (FDF)

Figure 5. Pharmaceutical Packaging

Figure 6. Pharmaceutical Products and CMO Revenue Market Share by Application in 2021

Figure 7. Specialty/Midsize Picture

Figure 8. Generics Picture

Figure 9. Big Pharma Picture

Figure 10. Others Picture

Figure 11. Global Pharmaceutical Products and CMO Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Pharmaceutical Products and CMO Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Pharmaceutical Products and CMO Revenue Market Share by Region (2017-2028)

Figure 14. Global Pharmaceutical Products and CMO Revenue Market Share by Region in 2021

Figure 15. North America Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Pharmaceutical Products and CMO Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Pharmaceutical Products and CMO Market Drivers

Figure 21. Pharmaceutical Products and CMO Market Restraints

Figure 22. Pharmaceutical Products and CMO Market Trends

Figure 23. Catalent Recent Developments and Future Plans

Figure 24. DPx Recent Developments and Future Plans

Figure 25. Lonza Recent Developments and Future Plans

Figure 26. Piramal Healthcare Recent Developments and Future Plans

Figure 27. Aenova Recent Developments and Future Plans

Figure 28. Jubilant Recent Developments and Future Plans

Figure 29. Famar Recent Developments and Future Plans

Figure 30. Boehringer Ingelheim Recent Developments and Future Plans

Figure 31. Fareva Holding Recent Developments and Future Plans

Figure 32. AbbVie Recent Developments and Future Plans

Figure 33. Nipro Corp Recent Developments and Future Plans

Figure 34. Vetter Recent Developments and Future Plans

Figure 35. Sopharma Recent Developments and Future Plans

Figure 36. Mylan (DPT Laboratories) Recent Developments and Future Plans

Figure 37. Recipharm Recent Developments and Future Plans

Figure 38. NextPharma Technologies Recent Developments and Future Plans

Figure 39. Dishman Recent Developments and Future Plans

Figure 40. Aesica Recent Developments and Future Plans

Figure 41. Global Pharmaceutical Products and CMO Revenue Share by Players in 2021

Figure 42. Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 43. Global Top 3 Players Pharmaceutical Products and CMO Revenue Market Share in 2021

Figure 44. Global Top 10 Players Pharmaceutical Products and CMO Revenue Market Share in 2021

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 46. Global Pharmaceutical Products and CMO Revenue Share by Type in 2021

Figure 47. Global Pharmaceutical Products and CMO Market Share Forecast by Type (2023-2028)

Figure 48. Global Pharmaceutical Products and CMO Revenue Share by Application in 2021

Figure 49. Global Pharmaceutical Products and CMO Market Share Forecast by Application (2023-2028)

Figure 50. North America Pharmaceutical Products and CMO Sales Market Share by Type (2017-2028)

Figure 51. North America Pharmaceutical Products and CMO Sales Market Share by Application (2017-2028)

Figure 52. North America Pharmaceutical Products and CMO Revenue Market Share by Country (2017-2028)

Figure 53. United States Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Canada Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Mexico Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Europe Pharmaceutical Products and CMO Sales Market Share by Type (2017-2028)

Figure 57. Europe Pharmaceutical Products and CMO Sales Market Share by Application (2017-2028)

Figure 58. Europe Pharmaceutical Products and CMO Revenue Market Share by Country (2017-2028)

Figure 59. Germany Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. France Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. United Kingdom Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Russia Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Italy Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Asia-Pacific Pharmaceutical Products and CMO Sales Market Share by Type (2017-2028)

Figure 65. Asia-Pacific Pharmaceutical Products and CMO Sales Market Share by Application (2017-2028)

Figure 66. Asia-Pacific Pharmaceutical Products and CMO Revenue Market Share by Region (2017-2028)

Figure 67. China Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Japan Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South Korea Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. India Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Southeast Asia Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Australia Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South America Pharmaceutical Products and CMO Sales Market Share by Type (2017-2028)

Figure 74. South America Pharmaceutical Products and CMO Sales Market Share by Application (2017-2028)

Figure 75. South America Pharmaceutical Products and CMO Revenue Market Share by Country (2017-2028)

Figure 76. Brazil Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Argentina Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Middle East and Africa Pharmaceutical Products and CMO Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Pharmaceutical Products and CMO Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Pharmaceutical Products and CMO Revenue Market Share by Country (2017-2028)

Figure 81. Turkey Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Saudi Arabia Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. UAE Pharmaceutical Products and CMO Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source